Hunter Williams
→ profileProtocol systematizer
Baseline (2023 Cheat Sheet)
- Dose
- 200 mcg
- Frequency
- 5 days on, 2 days off
- Timing
- PM
- Duration
- 8 weeks on, 8 weeks off
- Reconstitution
- 10 mg vial + 3 mL BAC
- Insulin units (1 mL)
- 6
Cautions
- **Experts do not explicitly differentiate "no DAC" from the parent CJC-1295 card in this corpus** — every dose, route, and frequency cited below is identical to what the experts teach for CJC-1295 generally; the no-DAC distinction surfaces only as preference statements (Hunter/Taylor prefer no-DAC for shorter half-life and more pulsatile release; Trevor prefers DAC for sustained IGF elevation). Treat this card as a pointer to the parent CJC-1295 card with the no-DAC preference flagged.
- Pair only with a GHRP, never another GHRH: Hunter email (2025-11-11): "You don’t combine multiple GHRH analogs (like CJC + Tesamorelin + Sermorelin). That’s just three versions of the same signal" and "what you do want is one GHRH analog + one GHRP."
- Flushing/heart rate at higher doses: Hunter email (2025-10-10): "CJC-1295 no DAC at 300 mcg gave me super flushing and a higher heart rate. Should I drop to 200 mcg for a bit?" Answer: "Yes. That warm, flushed “rush” is common when you jump in hot with CJC. Titrate down to 150–200 mcg until your body adapts." Taylor (00:10:43.000): "a lot of the flushing kind of comes from the CJC not So Much from the epin."
- Water retention with CJC: Taylor (00:10:53.480): "it can retain water so that’s another reason why I like take it at night."
- DAC vs no-DAC dispute (the core reason this card exists separately): Trevor (00:09:27.279): "CJC with DAC, and this isn’t a matter of debate” the peptide circulates for over a week"; Taylor (00:04:50.000): "I personally am never going to recommend using CJC with Dak because that is something that you’re going to have harsher side effects with CJC with no deck you don’t get the harsh side effects."
- Pituitary desensitization if uncycled: Trevor (00:37:11.200): "you will 100% demolish your pituitary in about 16 weeks. Your GHR and ghrein receptors will undergo something called clatherine mediated endoccytosis."
- Cancer caveat (active malignancy): Trevor (00:28:28.360): "if you have cancer, no, you shouldn’t take it. If you don’t, you are restoring a vital health parameter." Trevor (00:26:51.080): "It can help an existing cancer? Yeah, grow faster. But it does not cause cancer."
- Carbs/insulin blunt response: Trevor (00:23:53.200): "Taking it with food, especially carbs, blunts the release" and (00:24:02.080): "elevated blood glucose and insulin suppress growth hormone secretion."
- Always isolate first: Hunter email (2025-11-11): "Always use each compound in isolation first. That’s how you learn your own response."
- Hunter 2023 cheat-sheet baseline (no-DAC specifically): 10 mg vial reconstituted in 3 mL BAC water, 200 mcg dose = 6 units on a 1 mL insulin syringe, PM, 5 days on / 2 days off, 8 weeks on / 8 weeks off — treat as floor; newer transcript content above narrows the conservative dose to 100–200 mcg.
Taylor Williams
→ profileFemale-focused HRT + peptides
No content captured for this peptide from this expert.
Dr Trevor Bachmeyer
→ profileAcute vs chronic specialist
No content captured for this peptide from this expert.
Ask the CJC-1295 No DAC Librarian
Answers cite Hunter Williams, Taylor Williams, and Dr Trevor Bachmeyer only — no invented content.
Ask a question about CJC-1295 No DAC: dosing, timing, female-specific considerations, acute vs chronic context, stacking, contraindications.
Research educational use only. Not medical advice. Citations only — no invented content.
Disclaimer — For Research Purposes Only
All content on this page is for research and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any peptide or hormone protocol. You take responsibility for your own protocol. Members who want access can read about the member-owned co-op on our co-op page.